Non-invasive Haemodynamic Assessment in Hypertension (FINE-PATH)
Arterial Hypertension

About this trial
This is an interventional diagnostic trial for Arterial Hypertension focused on measuring arterial hypertension, hemodynamics, impedance cardiography, hypotensive therapy
Eligibility Criteria
Inclusion Criteria:
- untreated AH (elevated BP values ≥ 3 months) and insufficiently controlled AH by one or two antihypertensive drugs.
Exclusion Criteria:
- confirmed secondary AH,
- improperly controlled AH with three or more medicines
- chronic renal failure in the third and higher stages of the disease,
- other severe concomitant diseases: systolic heart failure, cardiomyopathy, significant cardiac arrhythmia, significant valvular disease, chronic obstructive pulmonary disease (stage C/D), diabetes, previously undetected, polyneuropathy, peripheral vascular disease,
- body mass index (BMI) > 40 kg/m2,
- mental illness, preventing cooperation with the physician,
- heart rhythm other than sinus (including, i.e. constant heart stimulation),
Sites / Locations
- Military Institute of Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Hemodynamic group
Empiric Group
The treatment choice based on hemodynamic parameters established with ICG method. Monotherapy or combined therapy in case of 1/ complex hemodynamic disturbances and/or 2/ office SBP ≥ 160 mm Hg and/or DBP ≥ 100 mmHg and/or 24-h mean SBP ≥ 140 mm Hg and/or 24-h mean DBP ≥ 90 mm Hg
The treatment choice based on current guidelines (blinded to ICG). Monotherapy or combined therapy in case of office SBP ≥ 160 mm Hg and/or DBP ≥ 100 mmHg and/or 24-h mean SBP ≥ 140 mm Hg and/or 24-h mean DBP ≥ 90 mm Hg